Q3 Performance: Growth Mixed with Setbacks
If you thought 2026 was going to be a breeze for Stoneridge Inc. (NYSE:SRI), think again. This quarter, the company reported some sales growth, but they're also battling a hefty arbitration loss that's thrown a wrench into their plans. Let’s dive into the numbers before I spill more beans on what this means for investors hoping to see their portfolios fatten up.
Staying Afloat in Harsh Waters
First off, reported sales zipped up by 12.4% year-over-year to $155.8 million. This isn’t peanuts, but it includes a painful $24.2 million hit due to an arbitration decision gone sour. Without this sticky issue, adjusted sales skyrocket to $180 million, marking a 29.9% spike compared to the last year.
"Despite harsh winds of inflation and supply turmoil, we kept a steady hand," claimed CEO Natalia Noblet, steering the ship with a steady hand.
But hang on—it ain't all sunshine and roses. They've got their MirrorEye tech doing wonders, pulling in more than $37 million of the haul. Stoneridge Brazil chipped in with $21.5 million—record numbers for their playbook. Clearly, they have a few tricks up their sleeve.
Financial Gymnastics Amid Challenges
Turning to costs and efficiencies, Stoneridge showed some savvy. They trimmed SG&A expenses by 317 basis points to a neat 13.1%. Kudos for trying to save a nickel where possible, adding up to over $5 million trimmed this year. But let's not get ahead of ourselves—the bottom line isn’t all rosy.
The Big Arbitration Cloud
What bites harder is the $22.9 million loss from continuing operations. Chalk that up to the arbitration heat, which pummeled them with a €22.5 million judgment over some legacy warranty beef. So, not exactly diving for suntans over there.
- Adjusted EBITDA bloated to $7.3 million, a 41.7% rise from last year’s $5.2 million. Healthy, indeed, but still feels like patching a leaky boat in a hurricane.
- And let’s not forget a troubling gross margin dive, dipping to 7.4% from a previous 23.1%. Slippery slopes, folks.
Noblet and the team haven’t raised the white flag yet. They’re pushing ahead, looking to squeeze out all the value possible from solutions like vision systems in the OEM sphere—a multi-year $180 million jackpot on the horizon, if all goes well.
Outlook: Adjusting the Sails
With the arbitration cloud temporarily settling, let's talk guidance. Initially, they predicted $645 to $670 million in sales. Now, they’re seeing around $690 to $700 million. Encouraging? Sure, but the adjusted EBITDA now hovers at the lower end of hopes—echoes of those inflationary knocks and currency squalls.
Gazing into the 2027 Crystal Ball
“We’ve sorted some nagging warranty and inventory kinks,” Noblet says, “and while demand’s perking up, cost disruptions remain a termite in the woodwork.” For the cautious optimists among us, Stoneridge is hustling to reassess their cost and refinancing game plan. No crystal terraces here—still a slog through market and geopolitical brawls.
So, okay, Stoneridge is playing an intense match. With demand expected to rise, especially across American and European clients, they might just pull ahead. But don't toss your lucky shirt yet—the game's still full of surprises.
